Dr David Dodwell
BSc, MD, FRCP, FRCR
Senior Clinical Research Fellow
I am a senior breast oncologist based in Leeds with a number of research and governance activities. I am the lead oncologist on the Sloane, NHS screening & national HQIP breast cancer audits.
I am a senior clinical research fellow to the EBCTCG and a member of steering groups for 12 ongoing UK trials in breast cancer. I sit on the trial management committees for 3 trials.
I am UK lead for the SACT project (UK chemotherapy database) and chair the clinical group, which provides input and advice to this project to examine the safety, efficacy and cost-effectiveness of chemotherapy used in England.
Making progress in early breast cancer: Taking time or accepting risk?
Mannu GS. and Dodwell D., (2017), Eur J Cancer, 78, 24 - 27
Estimating the Risks of Breast Cancer Radiotherapy: Evidence From Modern Radiation Doses to the Lungs and Heart and From Previous Randomized Trials.
Taylor C. et al, (2017), J Clin Oncol, 35, 1641 - 1649
The radiological features, diagnosis and management of screen-detected lobular neoplasia of the breast: Findings from the Sloane Project.
Maxwell AJ. et al, (2016), Breast, 27, 109 - 115
Adjuvant treatment for breast cancer
Flatley MJ. and Dodwell DJ., (2016), Surgery (United Kingdom), 34, 43 - 46
Dose-finding study of weekly docetaxel, epirubicin and capecitabine, as first-line treatment in advanced breast cancer.
Waters SH. et al, (2009), Cancer Chemother Pharmacol, 64, 407 - 412